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Abstract 
Aim  To determine whether sex differences in the prevalence of the metabolic syndrome and 
its components differ among different ethnic groups. 
Methods  A random sample of non-institutionalized adults aged 35–60 years in Amsterdam, 
the Netherlands (white Dutch men n = 242, women n = 244; African-Surinamese men 
n = 193, women n = 399, Hindustani-Surinamese men n = 149, women n = 186). The 
metabolic syndrome was defined according to the International Diabetes Federation criteria.  
Results  In all ethnic groups, the prevalence of central obesity and reduced HDL cholesterol 
were higher in women than in men, but the prevalence of elevated blood pressure, fasting 
glucose and triglycerides were lower in women than in men. However, the magnitude of the 
differences varied. The sex differences in the prevalence of central obesity and reduced HDL 
cholesterol were particularly larger in ethnic minority groups, especially in African-
Surinamese than in white Dutch. After adjustment for education, smoking, alcohol intake and 
physical activity, the prevalence of the metabolic syndrome was lower in white Dutch women 
than in white Dutch men (adjusted prevalence ratio 0.70, 95% CI 0.52–0.94). By contrast, the 
prevalence of the metabolic syndrome was higher in African-Surinamese women than in 
African-Surinamese men (adjusted prevalence ratio 1.56, 95% CI 1.12–2.18). Among 
Hindustani-Surinamese, men and women had a similar prevalence of the metabolic syndrome 
(adjusted prevalence ratio 1.00, 95% CI 0.76–1.31).  
Conclusions  Our findings suggest different patterns in sex differences in the metabolic 
syndrome among the ethnic groups. The relatively high prevalence of central obesity in 
African-Surinamese women may underlie their higher prevalence of the metabolic syndrome. 
Strategies to improve metabolic profiles among African-Surinamese and white Dutch people 
need to take sex differences into account. 
 
Keywords  ethnicity, gender, metabolic syndrome 
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Introduction 
The metabolic syndrome is an important risk factor for the development of Type 2 diabetes 
[1–5]. The metabolic syndrome and its components have been observed in many settings and 
the influence of sex on its prevalence varies between populations in different settings [6]. In 
Europe, the earlier studies found the metabolic syndrome to be more prevalent in men than in 
women [6–9]. By contrast, in the USA, the prevalence of the metabolic syndrome was found 
to be similar between white American men and women, whereas higher prevalence rates were 
found among African-American and Mexican-American women than in African-American 
and Mexican-American men [10]. Recent epidemiological data indicate that the prevalence of 
the metabolic syndrome is on the increase and this increase has been steeper in women than in 
men during the last decade [11–12]. Recent studies in some European countries also indicate 
that the sex gap in the prevalence of the metabolic syndrome may be closing [13–15].  
 
The increasing prevalence of the metabolic syndrome in women is thought to be largely 
attributable to the steady rise in obesity in women [12], and the prevalence of obesity is 
particularly high among ethnic minority women living in Europe and North America [16–18]. 
Evidence also indicates that the increasing prevalence of obesity has been steeper in ethnic 
minority women than in their white counterparts in the last decade [16].  
 
In Europe, only a few studies, mainly in the UK, have assessed ethnic differences in the 
prevalence of the metabolic syndrome [9,19]. Studies on sex difference in metabolic 
syndrome prevalence among different ethnic groups are rare in Europe. It is also unknown 
whether the prevalence of the metabolic syndrome and its components differ by sex in 
different ethnic groups in different European countries. The aim of this paper was therefore to 
determine whether sex differences in the prevalence of the metabolic syndrome and its 
components vary among different ethnic groups. We hypothesized that the prevalence of the 
metabolic syndrome would be higher in ethnic minority women than in men. 
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Patients and methods 
Study population 
The SUNSET study was a cross-sectional study that aimed to assess the cardiovascular risk 
factors among three ethnic groups in the Netherlands: African-Surinamese, Hindustani-
Surinamese and white Dutch people. Details of the study methods have been published 
elsewhere [20–21]. Briefly, the study was based on a sample of 35- to 60-year-olds in South 
Amsterdam, the Netherlands. Approximately 2975 individuals were randomly selected from 
the Amsterdam population register. People in these samples were approached for an oral 
interview between 2001 and 2003. The overall response rate was 60% among the Surinamese 
and 60% among the white Dutch people. Those who responded to the oral interview were 
invited for medical examination. The subsequent response rate was 84% among the 
Surinamese and 90% among the white Dutch. All participants signed a consent form. The 
Medical Ethical Committee of the Amsterdam Academic Medical Centre approved the study 
protocols. 
 
Measurements 
Ethnic groups were classified according to the self-reported ethnic origin [20]. Waist 
circumference was measured to the nearest centimetre at midway between the lower rib 
margin and the iliac crest with an ordinary tape measure. Blood pressure was measured in the 
morning with a validated oscillometric automated digital blood pressure device (Omron M-4; 
XXXXX, XXXX, Japan) by trained staff in the Academic Medical Centre. Using appropriate 
cuff sizes, two readings were taken on the right arm in a seated position after the subject had 
emptied their bladder and had been seated for at least 5 min. The mean of the two readings 
was used in the analyses. Fasting venous blood was taken for the measurement of fasting 
glucose (HK/glucose-6-P dehydrogenase test; Roche Diagnostics, XXXXX, XXXXX), HDL 
cholesterol (homogenous enzymatic colorimetric test; Roche Diagnostics) and triglycerides 
(GPO-PAP enzymatic test; Roche Diagnostics). Information on demographics, education, 
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physical activity, alcohol consumption and medical history was obtained during the 
participant's interview. The metabolic syndrome was defined according to the recent 
International Diabetes Federation criteria [23–24].  
 
Data analysis 
Baseline data were expressed as means or percentages. Sex difference in the metabolic 
syndrome and its components were assessed in each ethnic group by means of Poisson 
regression analyses with robust variance [25]. Statistical analyses were performed using Stata 
version 11.0 (StataCorp, College Station, TX, USA).  
 
Results 
Of the 1444 who attended the physical examination, 1413 people had complete data on the 
metabolic syndrome. The prevalence of alcohol consumption was lower in women than in 
men in all ethnic groups (Table 1). The mean BMI and the prevalence of smoking were higher 
in African-Surinamese and Hindustani-Surinamese women than in their male counterparts. 
African-Surinamese women played sports less often than African-Surinamese men. 
 
In all ethic groups, women had a higher prevalence of central obesity, but had lower 
prevalence of elevated blood pressure, fasting glucose and triglyceride levels than men, 
although not all the differences were statistically significant. African-Surinamese women had 
a higher prevalence of reduced HDL cholesterol than African-Surinamese men. The 
magnitude of the differences varied between the ethnic groups. After adjustment for age, 
educational level, smoking, alcohol consumption, playing sports, the adjusted prevalence ratio 
of central obesity was 1.18 (95% CI 1.01–1.36) in white Dutch women compared with white 
Dutch men; adjusted prevalence ratio 2.29 (95% CI 1.85–2.84) in African-Surinamese women 
compared with Africa-Surinamese women; and adjusted prevalence ratio 1.26 (95% CI 1.09–
1.45) in Hindustani women compared with Hindustani-Surinamese men, respectively (Fig. 1). 
The prevalence of the metabolic syndrome was lower in white Dutch women than in white 
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Dutch men (adjusted prevalence ratio 0.70, 95% CI 0.52–0.94). By contrast, African-
Surinamese women had a higher prevalence of the metabolic syndrome than African-
Surinamese men (adjusted prevalence ratio 1.56, 95% CI 1.12–2.18) while Hindustani men 
and women had a similar prevalence of the metabolic syndrome (adjusted prevalence 
ratio 1.00, 95% CI 0.76–1.31). There was evidence of sex–ethnicity multiplicative interaction 
for the metabolic syndrome (P < 0.01). 
 
Discussion 
Studies on sex differences in the prevalence of the metabolic syndrome and its components 
among different ethnic groups are rare in Europe [9]. Our current findings indicate different 
sex patterns in the prevalence of the metabolic syndrome among ethnic groups.  
 
Consistent with several earlier studies in Europe [6–9], we found a lower prevalence of the 
metabolic syndrome in white Dutch women than in white Dutch men. By contrast, African-
Surinamese women had a higher prevalence of the metabolic syndrome than African-
Surinamese men. Hindustani-Surinamese men and women had a similar prevalence of the 
metabolic syndrome. The comparatively high prevalence of the metabolic syndrome in 
African-Surinamese and the lack of difference between Hindustani men and women were 
largely attributable to the high prevalence of central obesity and, to a lesser extent, reduced 
HDL cholesterol in women. The percentage of sex differences in central obesity, for example, 
were 49 and 22% higher in African-Surinamese and Hindustani-Surinamese women than in 
their respective male counterparts, compared with 12% difference in the white Dutch group. 
Despite the higher prevalence of central obesity in ethnic minority women, the prevalence of 
Type 2 diabetes did not vary by sex. Presumably, this might be an effect of the ethnicity/sex 
specific cut-points. 
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The higher prevalence of the metabolic syndrome in African-Surinamese women in our 
current study is consistent with the finding in the USA [10,18]. In the National Health and 
Nutrition Examination Survey (NHANES) study, the prevalence of the metabolic syndrome 
was higher in African-American women than in African-American men [10,18]. In that study, 
central obesity was an important factor for the higher prevalence of the metabolic syndrome 
in African-American women compared with African-American men in the USA. The higher 
prevalence of central obesity among African-descent women may contribute to their observed 
high prevalence of the metabolic syndrome in both Europe and the USA.  
 
Our current findings among Hindustani-Surinamese populations, however, contrast the 
observations made on South Asian populations in the UK [9]. In the study of Unwin et al. 
study, South Asian men had a higher prevalence of the metabolic syndrome than South Asian 
women (46 vs. 38%) [9]. The explanations for the different patterns of the metabolic 
syndrome among the South Asian populations in the UK and the Netherlands are unclear. 
However, the magnitudes of the sex differences in the prevalence of the metabolic syndrome 
components such as central obesity and reduced HDL cholesterol were smaller in the UK than 
the Netherlands, which may contribute to observed differences between the two countries.  
 
Prevention of obesity is the main therapeutic goal in patients with the metabolic syndrome 
[29]. The importance of weight management in preventing progression of metabolic 
syndrome components has been demonstrated by the Coronary Artery Risk Development in 
Young Adults (CARDIA) study [30]. Weight reduction is optimally achieved with a multi-
modality approach, including physical activity and diet [30]. Given the beneficial effects of 
physical activity on weight reduction, promotion of physical activity may help to bridge the 
gender gap in the metabolic syndrome, particularly in ethnic minority women in whom 
obesity is highly prevalent but physical activity levels are low.  
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The main strength of our study is the use of the current International Diabetes Federation 
definition, which incorporates ethnicity-specific cut-off points for waist circumferences [23–
24]. Our study also has limitations, including the cross-sectional nature of the study design 
and lack of data on other pertinent variables such as diet. Furthermore, some of the data such 
as playing sports and smoking were based on self-report, which may be subject to reporting 
bias. Finally, bias could have resulted from a differential selective response rate [21].  
 
In conclusion, our findings indicate different patterns in sex differences in prevalence of the 
metabolic syndrome among the ethnic groups. The relatively high prevalence of central 
obesity in African-Surinamese women may contribute to their high prevalence of the 
metabolic syndrome. Strategies to improve metabolic profiles among African-Surinamese and 
white Dutch people need to take gender differences into account. 
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Table 1  Characteristics of the study population stratified by gender in each ethnic group  
 
 
 
White Dutch 
 
   
 
African-
Surinamese   
 
 
 
 
 
Hindustani -Surinamese  
 Wom
en 
(n = 
244) 
Men  
(n = 
242) 
 
Difference  
(95% CI) 
  
Wome
n  
(n = 3
99) 
 
Men 
(n = 19
3) 
Difference  
(95% CI) 
  
Wome
n 
(n = 18
6) 
Men 
(n = 14
9)  
Difference  
(95% CI) 
Age (years)  47.6 
(7.0) 
48.1 
(6.6) 
–0.45 (–1.67 
to 0.76) 
 43.6 
(5.8) 
43.9 
(6.2) 
–0.42 (–
1.46 to 
0.62) 
 45.0 
(6.7) 
44.4  
(6.7) 
0.62 (–0.82 
to 2.07) 
BMI (kg/m2) 26.0 
(5.2) 
26.3 
(4.4) 
–0.30 (–1.15 
to 0.56) 
 29.5 
(5.8) 
26.1 
(4.7) 
3.39 (2.53 
to 4.26) 
 27.7 
(5.1) 
26.2 
(5.4) 
1.52 (0.37 
to 2.66) 
Waist circumference 
(cm) 
87.7 
(14.4
)  
96.0 
(12.5
)  
–8.27 (–
10.67 to –
5.87) 
 95.0 
(15.2) 
90.5 
(12.5) 
4.51 (2.20 
to 6.83) 
 93.9 
(12.3) 
95.0 
(12.6)  
–1.10 (–
3.99 to 
1.42) 
LDL cholesterol 
(mmol/l) 
3.49 
(0.9) 
3.75 
(0.9) 
–0.26 (–0.42 
to –0.09) 
 3.15 
(0.09) 
3.26 
(0.09) 
–0.11 (–
0.27 to 
0.06) 
 3.41 
(0.09) 
3.44 
(0.09) 
–0.03 (–
0.23 to 
0.17) 
Education to high* % 
74 
(30.6
) 
98 
(40.2
)  
–9.6 (–18.0 
to 1.1)  
79 
(20.0) 
31 
(16.1)  
3.9 (–0.3 to 
10.4)  
14 
(10.2)  
19 
(9.4) 
0.8 (–7.0 to 
7.2) 
Current smoking, yes 
% 
103 
(43.3
) 
97 
(42.2
) 
1.1 (–7.9 to 
10.0)  
96 
(28.2)  
96 
(55.5) 
–27.3 (–
36.1 to –
18.6)  
37 
(21.4) 
78 
(53.1) 
–31.7 (–
42.2 to –
22.0) 
Play sport, yes % 
104 
(43.0
)  
98 
(40.2
)  
2.8 (–6.0 to 
11.6)  
102 
(25.6)  
73 
(37.8)  
–12.2 (–
20.4 to –
4.2)  
48 
(25.8) 
48 
(32.2) 
–6.4 (–16.4 
to 3.4) 
Alcohol consumption, 
yes % 
184 
(78.6
) 
225 
(94.9
)  
–16.3 (–22.3 
to –10.3)  
174 
(53.1) 
144 
(80.5)  
–27.4 (–
35.4 to –
19.3)  
52 
(32.1) 
89 
(61.8)  
–29.7 (–
40.3 to –
18.7) 
Hypertension† % 
47 
(19.4
) 
88 
(36.1
) 
–16.7 (–24.5 
to –8.8)  
149 
(37.3)  
87 
(45.1) 
–7.8 (–16.2 
to 0.1)  
64 
(34.4) 
61 
(40.9) 
–6.5 (–17.0 
to 4.0) 
Diabetes mellitus‡ % 
14 
(5.8) 
19 
(7.8) 
–2.0 (–6.5 to 
2.5)  
51 
(12.8) 
23 
(11.9) 
0.9 (–4.8 to 
6.5)  
48 
(25.8 ) 
37 
(24.8) 
1.0 (–8.5 to 
10.4) 
 
Metabolic syndrome 
and components 
           
Elevated waist 
circumference§ % 
158 
(65.3
) 
130 
(53.3
) 
12.0 (3.0 to 
20.7)  
334 
(83.7) 
66  
(34.2) 
49.5 (41.9 
to 57.2)  
163 
(87.6) 
98 
(65.8) 
21.8 (12.8 
to 30.9) 
Elevated 
triglyceride** % 
40 
(16.5
) 
73 
(29.9
) 
–13.4 (–20.8 
to –6.0)  
38 
(9.5) 
25 
(13.0) 
–3.5 (–9.0 
to 2.1)  
21.5 
(21.5) 
50 
(33.6) 
–12.1 (–
21.7 to –
2.4) 
Reduced HDL 
cholesterol†† % 
52 
(21.5
)  
44 
(18.0
)  
3.5 (–3.7 to 
10.6)  
134 
(33.6) 
31 
(16.1) 
17.5 (10.5 
to 24.5)  
92 
(49.5) 
59 
(39.6) 
9.9 (–1.0 to 
20.6) 
Elevated blood 
pressure¶ % 
70 
(28.9
) 
123 
(50.4
)  
–21.5 (–30.0 
to –13.0)  
186 
(46.6) 
117 
(60.6) 
–14.0 (–
22.5 to –
05.6)  
95 
(51.1) 
78 
(52.4)  
– 1.3 (–12.1 
to 9.6) 
Elevated fasting 
glucose‡‡ % 
59 
(24.4
)  
96 
(39.4
) 
–15.0 (–23.2 
to  –6.8)  
138 
(34.6) 
75 
(38.9) 
–4.3 (–12.6. 
4.1)  
88 
(47.3) 
91 
(61.1) 
–13.8 (–
24.5 to –
3.1) 
Metabolic syndrome % 
65 
(26.9
) 
81 
(33.2
) 
–6.3 (–14.5 
to 1.8)  
146 
(36.6) 
40 
(20.7) 
15.9 (8.4 to 
23.3)  
95 
(51.1) 
77 
(51.7)  
–0.6 (–11.5 
to 10.2) 
 
Values are mean (SD) or number (percentages) and percentage or mean difference with corresponding 95% CIs.  
*Vocational school and above, i.e. 13 years of education (high). 
†Systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or being on anti-hypertensive therapy. 
‡Fasting glucose ≥ 7.0 mmol⁄l and⁄or self-reported Type 2 diabetes. 
§Waist circumference ≥ 94 cm in Dutch and African-Surinamese men and ≥ 90 cm in Hindustani men; and 80 cm in women in 
all ethnic groups.  
¶Systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg or anti-hypertensive drug treatment.  
**Triglycerides ≥ 1.7 mmol/l or drug treatment for elevated triglycerides.  
††HDL cholesterol ≥ 1.0 mmol/l in males and < 1.3 mmol/l in women or drug treatment for reduced HDL cholesterol.  
‡‡Fasting glucose > 5.5 mmol/l or drug treatment of increased glucose.  
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Figure 1  Adjusted prevalence ratios of the metabolic syndrome and its components by sex in each ethnic group. 
Men are the reference category in each ethnic group. Prevalence ratios were adjusted for age, educational level, 
smoking, alcohol consumption and physical activity. 
0.2 0.5 1 2 5
Hindustani-Surinamese 0.73 (0.56–0.95) 
African-Surinamese 0.77 (0.59–1.02) 
White Dutch 0.60 (0.46–0.80) 
Elevated fasting glucose
Hindustani-Surinamese 0.85 (0.65–1.12) 
African-Surinamese 0.72 (0.60–0.87) 
White Dutch 0.54 (0.43–0.70) 
Elevated blood pressure 
Hindustani-Surinamese 1.21 (0.90–1.64) 
African-Surinamese 2.11 (1.45–3.08) 
White Dutch 0.90 (0.60–1.35) 
Reduced HDL cholesterol 
Hindustani-Surinamese 0.88 (0.56–1.57) 
African-Surinamese 0.82 (0.45–1.49) 
White Dutch 0.51 (0.35–0.74) 
Elevated triglycerides 
Hindustani-Surinamese 1.26 (1.09–1.45) 
African-Surinamese 2.29 (1.86–2.84) 
White Dutch 1.18 (1.01–1.38) 
Central obesity
Metabolic syndrome components 
Hindustani-Surinamese 1.00 (0.76–1.31) 
African-Surinamese 1.56 (1.12–2.18) 
White Dutch 0.70 (0.52–0.94) 
Metabolic syndrome
Prevalence ratio 
(95% CI) 
